frequency int64 1 472k | HCPCS_Cd stringlengths 5 5 | HCPCS_Desc stringlengths 4 256 | rn float64 1 1 |
|---|---|---|---|
33 | J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1 |
12 | J1556 | Injection, immune globulin (bivigam), 500 mg | 1 |
137 | J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1 |
425 | J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1 |
332 | J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1 |
5 | J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | 1 |
4 | J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | 1 |
862 | J1602 | Injection, golimumab, 1 mg, for intravenous use | 1 |
93 | J1610 | Injection, glucagon hydrochloride, per 1 mg | 1 |
63 | J1627 | Injection, granisetron, extended-release, 0.1 mg | 1 |
11 | J1738 | Injection, meloxicam, 1 mg | 1 |
53 | J1930 | Injection, lanreotide, 1 mg | 1 |
3 | J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 1 |
1 | J1953 | Injection, levetiracetam, 10 mg | 1 |
219 | J1955 | Injection, levocarnitine, per 1 gm | 1 |
702 | J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1 |
150 | J2182 | Injection, mepolizumab, 1 mg | 1 |
24 | J2185 | Injection, meropenem, 100 mg | 1 |
1,370 | J2250 | Injection, midazolam hydrochloride, per 1 mg | 1 |
14 | J2280 | Injection, moxifloxacin, 100 mg | 1 |
96 | J2350 | Injection, ocrelizumab, 1 mg | 1 |
503 | J2357 | Injection, omalizumab, 5 mg | 1 |
6 | J2370 | Injection, phenylephrine hcl, up to 1 ml | 1 |
4 | J2407 | Injection, oritavancin (orbactiv), 10 mg | 1 |
1 | J2501 | Injection, paricalcitol, 1 mcg | 1 |
3 | J2507 | Injection, pegloticase, 1 mg | 1 |
8 | J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1 |
15 | J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | 1 |
3 | J2562 | Injection, plerixafor, 1 mg | 1 |
499 | J2704 | Injection, propofol, 10 mg | 1 |
23 | J2720 | Injection, protamine sulfate, per 10 mg | 1 |
12 | J2760 | Injection, phentolamine mesylate, up to 5 mg | 1 |
2 | J2783 | Injection, rasburicase, 0.5 mg | 1 |
255 | J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1 |
1,010 | J3010 | Injection, fentanyl citrate, 0.1 mg | 1 |
24 | J3032 | Injection, eptinezumab-jjmr, 1 mg | 1 |
499 | J3111 | Injection, romosozumab-aqqg, 1 mg | 1 |
91 | J3145 | Injection, testosterone undecanoate, 1 mg | 1 |
9 | J3241 | Injection, teprotumumab-trbw, 10 mg | 1 |
81 | J3245 | Injection, tildrakizumab, 1 mg | 1 |
417 | J3262 | Injection, tocilizumab, 1 mg | 1 |
34,205 | J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1 |
1,294 | J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1 |
57 | J3357 | Ustekinumab, for subcutaneous injection, 1 mg | 1 |
1 | J3358 | Ustekinumab, for intravenous injection, 1 mg | 1 |
407 | J3380 | Injection, vedolizumab, 1 mg | 1 |
284 | J3411 | Injection, thiamine hcl, 100 mg | 1 |
298 | J3415 | Injection, pyridoxine hcl, 100 mg | 1 |
5 | J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | 1 |
2,417 | J3490 | Unclassified drugs | 1 |
3,097 | J7030 | Infusion, normal saline solution , 1000 cc | 1 |
5 | J7170 | Injection, emicizumab-kxwh, 0.5 mg | 1 |
2 | J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | 1 |
1 | J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. | 1 |
1 | J7205 | Injection, factor viii fc fusion protein (recombinant), per iu | 1 |
506 | J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 1 |
3 | J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | 1 |
3 | J7314 | Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg | 1 |
866 | J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1 |
1,200 | J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 1 |
667 | J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 1 |
2,095 | J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 1 |
970 | J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 1 |
738 | J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 1 |
106 | J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 1 |
192 | J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 1 |
29 | J7333 | Hyaluronan or derivative, visco-3, for intra-articular injection, per dose | 1 |
9 | J7336 | Capsaicin 8% patch, per square centimeter | 1 |
631 | J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 1 |
144 | J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | 1 |
1,234 | J7999 | Compounded drug, not otherwise classified | 1 |
53 | J9022 | Injection, atezolizumab, 10 mg | 1 |
895 | J9030 | Bcg live intravesical instillation, 1 mg | 1 |
10 | J9034 | Injection, bendamustine hcl (bendeka), 1 mg | 1 |
2 | J9040 | Injection, bleomycin sulfate, 15 units | 1 |
5 | J9043 | Injection, cabazitaxel, 1 mg | 1 |
2 | J9044 | Injection, bortezomib, not otherwise specified, 0.1 mg | 1 |
190 | J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 1 |
74 | J9145 | Injection, daratumumab, 10 mg | 1 |
26 | J9173 | Injection, durvalumab, 10 mg | 1 |
1 | J9176 | Injection, elotuzumab, 1 mg | 1 |
1 | J9185 | Injection, fludarabine phosphate, 50 mg | 1 |
1,396 | J9190 | Injection, fluorouracil, 500 mg | 1 |
3 | J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg | 1 |
199 | J9206 | Injection, irinotecan, 20 mg | 1 |
7 | J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units | 1 |
2 | J9227 | Injection, isatuximab-irfc, 10 mg | 1 |
10 | J9228 | Injection, ipilimumab, 1 mg | 1 |
1 | J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg | 1 |
70 | J9260 | Methotrexate sodium, 50 mg | 1 |
578 | J9263 | Injection, oxaliplatin, 0.5 mg | 1 |
1,548 | J9271 | Injection, pembrolizumab, 1 mg | 1 |
470 | J9299 | Injection, nivolumab, 1 mg | 1 |
2 | J9301 | Injection, obinutuzumab, 10 mg | 1 |
5 | J9306 | Injection, pertuzumab, 1 mg | 1 |
17 | J9311 | Injection, rituximab 10 mg and hyaluronidase | 1 |
500 | J9312 | Injection, rituximab, 10 mg | 1 |
1 | J9352 | Injection, trabectedin, 0.1 mg | 1 |
313 | J9395 | Injection, fulvestrant, 25 mg | 1 |
2 | K0739 | Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.